JENNIFER LUTZ: Open Payments
NPI 1104548429 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$745 in 43 payments from 11 companies in 2025. Trend: 2023 $7 · 2024 $458 · 2025 $745
Food & beverage: $745
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 17 | $184 |
| Novartis Pharmaceuticals Corporation | 8 | $161 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $110 |
| Otsuka America Pharmaceutical, Inc. | 4 | $92 |
| Vifor Pharma, Inc. | 3 | $56 |
| Amgen Inc. | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $30 |
| Calliditas Therapeutics US Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $20 |
| Aurinia Pharma U.S., Inc. | 1 | $20 |
Products named: JARDIANCE, Kerendia, Fabhalta, JYNARQUE, Veltassa, TAVNEOS, FARXIGA, Vanrafia.
Industry payments across VA — which companies pay providers there.
